Xuanwu Hospital, Beijing: Cerebral Infarction trials

The registry lists 13 Cerebral Infarction studies with Xuanwu Hospital, Beijing as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 2No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Phrenic Nerve Stimulation for Reducing Ventilation Duration in Acute Cerebral Infarction: A Multicenter Randomized Controlled TrialNot yet recruitingNCT07133932Not applicable
• Efficacy of Probucol Combined with Statins Treatment for Ischemic StrokeRecruitingNCT06604117
• Remote Ischemic Conditioning for Cerebral Ischemia in Patients With Takayasu Arteritis (TARIC-1)RecruitingNCT06178419Not applicable
• Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic StrokeNot yet recruitingNCT06134635
• Registry of Acute Ischemic Stroke With Large- or Medium-vessel OcclusionRecruitingNCT05779215
• Effectiveness and Safety of Edaravone Dexborneol in Acute Ischemic StrokeRecruitingNCT05644223
• XuanwuH Acute Ischemic Stroke RegistryRecruitingNCT05208203
• Comprehensive Assessment of Atherosclerotic Ischemic Stroke Risk and Development of a Prediction ModelActive, not recruitingNCT06315153
• The MRI-based Evaluation of Safety and Efficacy of EVT and SMT: A Retrospective, Multicenter StudyCompletedNCT06236828
• The Safety and Efficacy of Embotrap in Treating Acute Ischemic Stroke PatientsStatus unknownNCT05667103Not applicable
• Combination of the Immune Modulator Dimethyl Fumarate With Alteplase in Acute Ischemic StrokeStatus unknownNCT04890366Phase 1/2
• Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic StrokeTerminatedNCT04890353Phase 1/2
• Registration Study of Acute Ischemic Stroke/Transient Ischemic Attack (TIA) With Atrial FibrillationStatus unknownNCT04080830